Table 1.
Clinical characteristics of melanoma patients and the comparison between cutaneous and mucosal melanomas.
| Variables | Variables | Melanoma (N = 82) | Cutaneous Melanoma (N = 45) | Mucosal melanoma (N = 37) |
|---|---|---|---|---|
| Median age | 62 | 64 | 59 | |
| Age category | <65 | 49 (60%) | 23 (51%) | 23 (62.2) |
| 65–75 | 17 (20.5%) | 13 (29%) | 7 (18.9%) | |
| >75 | 16 (19.5%) | 9 (20%) | 7 (18.9) | |
| Sex | Male | 30 (36.6%) | 16 (35.6%) | 14 (37.8%) |
| Female | 52 (63.4%) | 29 (64.4%) | 23 (62.2%) | |
| Histological subtype type | SSM | 0 (0%) | 0 (0%) | 0 (0%) |
| ALM | 12 (14.6%) | 12 (26.7%) | 0 (0%) | |
| NM | 33 (40.2%) | 33 (73.3%) | 0 (0%) | |
| LMM | 0 (0%) | 0 (0%) | 0 (0%) | |
| Mucosal | 37 (45.2%) | 0 (0%) | 37 (100%) | |
| Breslow tumor thickness | T1 | 1 (%) | 0 (%) | 1 (2.7%) |
| T2 | 7 (%) | 0 (%) | 7 (18.9%) | |
| T3 | 11 (%) | 0 (%) | 11 (29.7%) | |
| T4 | 63 (%) | 45 (100%) | 18 (48.6%) | |
| Ulceration | Yes | 24 (29.3%) | 24 (53.3%) | 0 (0%) |
| No | 58 (70.7%) | 21 (46.7%) | 37 (100%) | |
| Diameter | ≤6 mm | 8 (9.8%) | 2 (4.4%) | 6 (16.2%) |
| >6 mm | 74 (90.2%) | 43 (95.6%) | 31 (83.8%) | |
| Node | N0 | 42 (51.2%) | 11 (24.4%) | 31 (83.4%) |
| N1 | 7 (8.5%) | 4 (8.9%) | 3 (8.1%) | |
| N2 | 10 (12.2%) | 9 (20%) | 1 (2.7%) | |
| N3 | 23 (28.1%) | 21 (46.7%) | 2 (5.4%) | |
| AJCC stage | I | 4 (4.9%) | 0 (0%) | 4 (10.8%) |
| II | 15 (18.3%) | 11 (24.4%) | 4 (10.8%) | |
| III | 52 (63.4%) | 34 (75.6%) | 18 (48.6%) | |
| IV | 11 (13.4%) | 0 (0%) | 11 (29.7%) | |
| Location | Acral | 13 (15.8%) | 13 (28.9%) | 0 (0%) |
| Head/neck | 2 (2.4%) | 2 (4.4%) | 0 (0%) | |
| Trunk | 1 (1.2%) | 1 (2.2%) | 0 (0%) | |
| Extremities | 29 (35.3%) | 29 (64.4%) | 0 (0%) | |
| Mucosal | 37 (45.2%) | 0 (0%) | 37 (100%) | |
SSM: superficial spreading melanoma.
ALM: acral lentiginous melanoma.
NM: nodular melanoma.
LMM: lentigo malign melanoma.